In this retrospective single-center study, we examined if a standardized WCD training and adherence surveillance programme could enhance compliance and QoL. Due to the constant risk of fatal arrhythmias, compliance is the fundamental requirement for effectiveness of a WCD, but this might be hindered by the poor quality-of-life (QoL) during WCD therapy. 15, Munich, DE-81377, Germany, Tel +49 89 4400 712621, Email īackground: Treatment with wearable cardioverter defibrillators (WCD) is a non-invasive, transient therapy option for prevention of sudden cardiac death (SCD) in patients with temporary contraindications for implantation of a permanent cardioverter defibrillator. Antonia Kellnar, 1 Stephanie Fichtner, 2 Lauren Sams, 1 Christopher Stremmel, 1 Heidi L Estner, 1 Korbinian Lackermair 1ġDepartment of Medicine I, University Hospital Munich, Ludwig Maximilian University, Munich, Germany 2Department of Cardiology, Krankenhaus Landshut-Achdorf, Landshut, GermanyĬorrespondence: Antonia Kellnar, Department of Medicine I, University Hospital Munich, Marchioninistr.

Ibm license key center spss